Latest Breaking News On - V gfor us3842721009 - Page 1 : comparemela.com

NKGen Biotech, Inc. , a clinical stage Natural Killer cell therapy company, has entered into a merger agreement with Graf Acquisition Corp. IV . | April 17, 2023

United statesNew york stock exchangeNew yorkJames grafTony kuznikSabrina mckeeAnthonya kuznikDenise chuaCo ltdYork stock exchangeWhite caseNkgen biotech incExchange commissionGraf acquisition corpNatural killerGraf acquisition